Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
Regenerative Medical Technology Group Inc.
- Market Cap
- Unavailable
- Price
- $0.0597
- % Change (Daily % change from the live per-ticker quote feed.)
- +13.71%
- Volume
- 600
About
Regenerative Medical Technology Group Inc. operates in the regenerative medicine industry in the United States and internationally. It provides products, solutions, equipment, services, and training to doctors and their staff in the application of stem cell therapies. The company is also involved in the treatment of patients; provision of training and seminars; and resale of kits, products, equipment, and services. In addition, it offers reoccurring application of its process using its kits and solutions. The company was formerly known as Meso Numismatics, Inc. and changed its name to Regenerative Medical Technology Group Inc. in May 2024. Regenerative Medical Technology Group Inc. was incorporated in 1999 and is based in Boca Raton, Florida.
Quick stats
Shares outstanding—
Computed float12.1M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryBiotechnology
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001760026
AI Summary
AI-generated1/7
minorbullishoperations update
RMTG Provides Details for First-Ever Investor Call to Answer Shareholder Questions
RMTG announced details for its first-ever investor call scheduled for August 20, 2026, where management will present prepared remarks based on shareholder-submitted questions.
The company cited strong performance in the first half of 2026 and increased transparency as drivers for the call, though it explicitly stated there will be no live Q&A or discussion of Q2 financial results.
CEO David Christensen noted encouragement regarding the company's progress and its focus on executing within the regenerative medicine field.
Red flags
- Forward-looking statements cite risk regarding the company's ability to continue as a going concern
- Boilerplate flags include liquidity constraints and substantial debt obligations